Skip to main content
. 2019 Jun 28;39(6):BSR20182356. doi: 10.1042/BSR20182356

Table 2. Logistic regression analysis of associations between rs1805034 polymorphism and the risk of RA.

Genotype Cases (n=574) Controls (n=804) OR (95% CI), P Adjusted OR (95% CI); P
n % n %
RANK rs1805034
TC vs. TT 253/266 44.3/46.6 324/386 41.3/49.2 1.13 (0.90, 1.42), 0.280 1.13 (0.90, 1.42); 0.287
CC vs. TT 52/266 9.1/46.6 75/386 9.5/49.2 1.01 (0.68, 1.48), 0.975 0.99 (0.77, 1.27); 0.992
CC+TC vs. TT 305/266 53.4/46.6 399/386 50.8/49.2 1.11 (0.89, 1.38), 0.347 1.11 (0.89, 1.37); 0.360
CC vs. TC+TT 52/519 9.1/90.9 75/710 9.5/90.5 0.95 (0.64, 1.38), 0.780 0.94 (0.65, 1.37); 0.749
C vs. T 357/785 31.3/68.7 474/1096 30.2/69.8 1.05 (0.89, 1.24), 0.551 NA

Adjusted for age and sex. Abbreviation: NA, not available.

HHS Vulnerability Disclosure